FDA Removes Novo Nordisk's Ozempic and Wegovy from Drug Shortage List Amid Legal Challenge

Gelonghui June 18 | According to Reuters, a federal judge in Texas supported the decision of the U.S. Food and Drug Administration (FDA) to remove Novo Nordisk's best-selling drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge brought by compounding pharmacies seeking to continue replicating the drugs.